The University of Chicago Header Logo

Connection

John Fung to Incidence

Back to Details
This is a "connection" page, showing publications John Fung has written about Incidence.
John Fung
Connection Strength
0.784
Incidence
  1. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008 Oct; 14(10):1406-11.
    View in: PubMed
    Score: 0.058
  2. Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl. 2007 Dec; 13(12):1633-6.
    View in: PubMed
    Score: 0.054
  3. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005 Jun; 11(6):679-83.
    View in: PubMed
    Score: 0.046
  4. De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl. 2004 Jan; 10(1):1-6.
    View in: PubMed
    Score: 0.041
  5. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.038
  6. Fungal infection in liver transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:18-23.
    View in: PubMed
    Score: 0.036
  7. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 2001 Nov; 7(11 Suppl 1):S109-18.
    View in: PubMed
    Score: 0.036
  8. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation. 2001 Sep 27; 72(6):1091-7.
    View in: PubMed
    Score: 0.035
  9. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc. 2000 May; 32(3):663-4.
    View in: PubMed
    Score: 0.032
  10. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999 Sep; 5(5):421-8.
    View in: PubMed
    Score: 0.031
  11. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
    View in: PubMed
    Score: 0.030
  12. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg. 1999 Mar; 5(2):144-50.
    View in: PubMed
    Score: 0.030
  13. Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience. J Gastrointest Surg. 2019 11; 23(11):2201-2210.
    View in: PubMed
    Score: 0.030
  14. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci. 1998 Sep; 43(9):1931-7.
    View in: PubMed
    Score: 0.029
  15. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation. Inflamm Bowel Dis. 2016 07; 22(7):1670-8.
    View in: PubMed
    Score: 0.025
  16. Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford). 2013 Nov; 15(11):851-7.
    View in: PubMed
    Score: 0.019
  17. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.019
  18. Comparison of laparoscopic versus open liver tumor resection: a case-controlled study. Surg Endosc. 2009 Apr; 23(4):847-53.
    View in: PubMed
    Score: 0.015
  19. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004 Jun 15; 77(11):1719-25.
    View in: PubMed
    Score: 0.011
  20. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
    View in: PubMed
    Score: 0.010
  21. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003 May; 16(5):336-40.
    View in: PubMed
    Score: 0.010
  22. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View in: PubMed
    Score: 0.009
  23. An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant. 2001 May; 1(1):47-50.
    View in: PubMed
    Score: 0.009
  24. Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1134-5.
    View in: PubMed
    Score: 0.008
  25. Bacterial translocation in clinical intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1210.
    View in: PubMed
    Score: 0.008
  26. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.008
  27. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol. 1999 Aug; 66(2):310-4.
    View in: PubMed
    Score: 0.008
  28. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc. 1999 Feb-Mar; 31(1-2):1134.
    View in: PubMed
    Score: 0.007
  29. A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol. 1998 Dec; 160(6 Pt 1):1982-5; discussion 1985-6.
    View in: PubMed
    Score: 0.007
  30. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1998 Oct 27; 66(8):1047-52.
    View in: PubMed
    Score: 0.007
  31. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.007
  32. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation. 1997 Aug 15; 64(3):422-6.
    View in: PubMed
    Score: 0.007
  33. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
    View in: PubMed
    Score: 0.007
  34. Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. Gastroenterology. 1997 Apr; 112(4):1121-8.
    View in: PubMed
    Score: 0.006
  35. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc. 1997 Feb-Mar; 29(1-2):532-3.
    View in: PubMed
    Score: 0.006
  36. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res. 1996 Feb 01; 60(2):333-8.
    View in: PubMed
    Score: 0.006
  37. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation. 1995 Apr 15; 59(7):1010-4.
    View in: PubMed
    Score: 0.006
  38. Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int. 1995; 8(1):1-7.
    View in: PubMed
    Score: 0.006
  39. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994 Sep; 220(3):297-308; discussion 308-9.
    View in: PubMed
    Score: 0.005
  40. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994 Jan; 219(1):40-5.
    View in: PubMed
    Score: 0.005
  41. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4.
    View in: PubMed
    Score: 0.005
  42. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc. 1993 Jun; 25(3):2381-5.
    View in: PubMed
    Score: 0.005
  43. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3035-7.
    View in: PubMed
    Score: 0.004
  44. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990 Sep; 212(3):295-305; discussion 306-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.